← 產業報告目錄
AI in Biopharmaceutical Development Market Size, Share & Trends Analysis Report By Type (Monoclonal antibodies, Vaccines, Recombinant proteins), By Application (Research and discovery, Clinical Development, Manufacturing & supply chain and other subsegments), By End-User, By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-03-09頁數 185報告編號 INSIGHTACE-b855e091cc
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the AI in Biopharmaceutical Development Market worldwide was assessed at USD 991.0 Million. Analysts project it will expand to USD 13,518.8 Million by 2034, at a CAGR of 30.0% spanning 2025 to 2034.
At its core, AI in Biopharmaceutical Development pertains to key industry insights & findings from the report:
The need to reduce time in drug development and facilitation of editing gene structures is driving the artificial intelligence (ai) in biopharmaceuti. Stakeholders across the technology and communications landscape are risingly turning to these solutions to meet contemporary demands.
Growth is propelled by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the technology and communications sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI in Biopharmaceutical Development Market Snapshot
Chapter 4. Global AI in Biopharmaceutical Development Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of AI Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Monoclonal antibodies
5.2.2. Vaccines
5.2.3. Recombinant proteins
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology Type:
6.2.1. Research and discovery
6.2.2. Clinical development
6.2.3. Manufacturing & supply chain and other subsegments
Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis
7.1. By End-user & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
7.2.1. Biopharmaceutical manufacturers
7.2.2. Contract manufacturing organizations (CMOs) or contract research organizations (CROs)
7.2.3. Academic & government research institutes
Chapter 8. AI in Biopharmaceutical Development Market Segmentation 4 : Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Type, 2021-2034
8.1.2. North America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.1.3. North America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.1.4. North America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe AI in Biopharmaceutical Development Market revenue (US$ Million) by by Type, 2021-2034
8.2.2. Europe AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.2.3. Europe AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.2.4. Europe AI in Biopharmaceutical Development Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific AI in Biopharmaceutical Development Market revenue (US$ Million) by by Type, 2021-2034
8.3.2. Asia Pacific AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.3.3. Asia Pacific AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.3.4. Asia Pacific AI in Biopharmaceutical Development Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America AI in Biopharmaceutical Development Market revenue (US$ Million) by Type, 2021-2034
8.4.2. Latin America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.4.3. Latin America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.4.4. Latin America AI in Biopharmaceutical Development Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa AI in Biopharmaceutical Development Market revenue (US$ Million) by Type, 2021-2034
8.5.2. Middle East & Africa AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.5.3. Middle East & Africa AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.5.4. Middle East & Africa AI in Biopharmaceutical Development Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. IBM Watson Health
9.2.2. Google (Alphabet Inc.)
9.2.3. Concreto HealthAI
9.2.4. Nvidia Corporation
9.2.5. PathAI
9.2.6. Atomwise, Inc.
9.2.7. Deep Genomics
9.2.8. Cloud Pharmaceuticals, Inc.
9.2.9. Ai-biopharma S.A.S.
9.2.10. Microsoft Corporation
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們